Every year since 2007, the G-FINDER project has provided policymakers, donors, researchers, and the pharmaceutical industry with a comprehensive analysis of global investment in research and development (R&D) of new products to prevent, diagnose, control, or cure neglected diseases in low- and middle-income countries (LMICs).

This ‘Partner Perspective’ draws on the findings from the fourteenth annual G-FINDER report, launched on January 27, 2022, by Policy Cures Research (PCR), an Australia-based research and policy institute, which presents data on investments made in 2020.